Beta-adrenergic Receptor › [ REAL ]
-ARs exist inside neurons—not just on the surface—where they bind norepinephrine and activate downstream pathways that regulate synaptic strength, such as AMPA receptor phosphorylation.
-ARs are excluded from these areas upon activation, suggesting precise, spatially organized signaling.
While commonly used for heart conditions, beta-blockers have been found to act as proinflammatory agents in the brain, with research in PMC7686098 indicating that they impair microglia-mediated phagocytosis of synaptic material, increasing neuroinflammation. Chronic Heart Failure (CHF): β1beta sub 1 beta-adrenergic receptor
New studies utilize Rosetta structural modeling to map atomic-scale interactions of β1beta sub 1 β2beta sub 2
To give you the most relevant "deep paper" information, could you tell me: -ARs exist inside neurons—not just on the surface—where
-ARs are key regulators in embryonic development. They modulate actomyosin relaxation, allowing epithelial tissues to stretch during body elongation, as detailed in Cell.com . 4. Summary of Subtype Characteristics Primary Location Key Physiological Effect β1beta sub 1 Heart, Adipose tissue Increases heart rate & contractility β2beta sub 2 Smooth muscle (Airways), Immune Cells Bronchodilation, Vasodilation β3beta sub 3 Adipose tissue, Urinary bladder Lipolysis, Thermogenesis
with specific beta-blockers, allowing for state-specific modeling (active vs. inactive). 2. Emerging Roles in Disease Pathogenesis -adrenergic signaling (specifically Chronic Heart Failure (CHF): β1beta sub 1 New
Are you researching their role in a specific disease, like ?